South Pasadena, CA, United States of America

Stella Tommasi

This inventor holds 1 USPTO granted patent. Top assignee: Beckman Research Institute, City of Hope. Active years: 2013.


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Stella Tommasi

Introduction

Stella Tommasi is a prominent inventor based in South Pasadena, CA (US). She has made significant contributions to the field of molecular biology, particularly in the area of gene silencing. Her work has implications for therapeutic strategies in treating various diseases.

Latest Patents

Stella Tommasi holds a patent for her invention titled "Double stranded nucleic acid targeting low copy promoter-specific RNA." This invention relates to transcriptional gene silencing (TGS) in mammalian, including human, cells, mediated by small interfering RNA (siRNA) molecules. The invention also involves a double stranded nucleic acid that directs methylation of histones associated with target genes that produce low copy promoter-specific RNA. It has been discovered that siRNAs can effectively direct methylation of histones in mammalian cells.

Career Highlights

Stella Tommasi is affiliated with City of Hope, a leading research and treatment center. Her work at this institution has allowed her to explore innovative approaches to gene therapy and molecular biology. She has been recognized for her contributions to the scientific community and continues to advance research in her field.

Collaborations

Stella has collaborated with notable colleagues, including Gerd P Pfeifer and Daniela Castanotto. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation.

Conclusion

Stella Tommasi's work exemplifies the impact of innovative research in molecular biology. Her contributions to gene silencing and therapeutic strategies highlight the importance of scientific advancements in improving human health.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…